Elon Musk's Neuralink Is Working On Curing Blindness

Elon Musk's Neuralink has advanced significantly in recent years.
Elon Musk's Latest Venture: Using Neuralink To Cure Blindness.
Last Thursday, Elon Musk engaged in a fireside chat with famed startup accelerator Y Combinator. During the discussion, when asked about his brain-computer interface (BCI) venture, Neuralink, Musk revealed the incredible progress the company has achieved. Perhaps the most key development that the technology titan shared is that the company will soon be doing vision empowering implants to help those with blindness to see again.
This is a huge advancement; the company astounded the global tech community when it released its famed 'Monkey MindPong' demonstration just 4 years ago, showing a 9 year old Macaque monkey using a Neuralink BCI to control a video game using only its thoughts. Since then, Neuralink has advanced its technology rapidly, receiving FDA clearance for human trials 2 years ago. The company's vision is to 'restore autonomy to those with unmet medical needs and unlock new dimensions of human potential.' One primary way is to use the chip to restore function to those with paralytic conditions; the chip will relay the patients' brain signals to control computer systems and robotic arms.
The company's latest work, per Musk's remarks, involves an entirely novel angle: enabling people with blindness to experience vision. He commented that 'in the next 6 to 12 months, we'll be doing our first implants for vision, where even if somebody is completely blind, we can write directly to the visual cortex.' Reportedly, the company has already tested this: 'one of our monkeys has had the visual implant for 3 years,' Musk explained.
With this technology, though the actual sense of vision will not be restored, the chip will help directly write into the part of the brain that processes vision, meaning that users can potentially share a very similar experience. Musk also explained that initially, the chip may only enable low resolution processing at first, but with time, will certainly improve to higher resolutions. He mentioned that users may eventually be able to process 'multi-spectral wavelengths' including even 'ultraviolet and infrared bands'—perhaps akin to 'having a superpower.'
Undoubtedly, BCI technology has come a long way and the sector is rapidly growing. Last month, it was announced that Apple is working with its own BCI partners to develop technology so users can control its ecosystem using only their thoughts. Specifically, the company is partnering with Synchron, another big player in the BCI field, and Nvidia to establish the standards for BCI protocols. Most recently, Paradromics, another prominent name in the BCI space, completed its first human implant. Notably, the company has inked an important partnership with Saudi Arabia's Neom investment fund. Another famous name in the space is Precision Neuroscience, which recently secured the greenlight from the FDA on an important component in its wider ecosystem. Thus, the competition is certainly growing as the research and funding within this space has expanded significantly.
One major advantage that Neuralink has above the rest is that it works well in conjunction with Musk's other ventures; that is, Musk has the opportunity to leverage the best of his work across his wider business portfolio, incuding Tesla, SpaceX and xAI, to collaborate with Neuralink's technology. For example, Tesla's developments with its Optimus humanoid bot could potentially serve as a great conduit for Neuralink users to effectuate action with their thoughts. Additionally, the progress that xAI has made with deep learning capabilities may significantly augment Neuralink's work. Indeed, Musk's broader ecosystem, especially when working in conjunction, has significant potential in the years ahead.
Nevertheless, the entire BCI sector must remain focused on the key elements of patient safety and outcomes. The insertion procedures for these implants are incredibly intricate, and overall, the work being done requires an astounding amount of attention to detail. However, if executed correctly, the technology has incredible potential to significantly improve health outcomes.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Bloomberg

28 minutes ago

• Bloomberg

Ex-Soros Hedge Fund Picker Sun Leads Andon's Push Into US

Investment firm Andon Hong Kong Ltd. is opening an office in New York, led by Soros Fund Management alumnus Chuck Sun. The US operation will initially focus on hedge fund manager selection, an area in which Sun specialized at billionaire George Soros' family office. The firm manages money on behalf of Shenzhen-listed Andon Health Co., a Chinese maker of medical devices like blood pressure monitors and Covid test kits.

Bloomberg

28 minutes ago

• Bloomberg

Ford Escalates Battery Job Warnings as Congress Mulls EV Cuts

Ford Motor Co. intensified its campaign to preserve clean energy manufacturing subsidies Monday, warning jobs at its electric-vehicle battery plant in southwestern Michigan could be at risk if Republicans in Congress pare back tax credits in President Donald Trump's multi-trillion dollar economic package. The $3 billion plant in Marshall, about 100 miles west of Detroit, is slated to produce 20 gigawatt-hours of lithium iron phosphate, or LFP batteries, and employ 1,700 people after it starts production in 2026. The 2 million-square-foot site, which is still under construction, has drawn intense political scrutiny since it was announced in 2023 because Ford is licensing the technology to build the batteries from China's Contemporary Amperex Technology Co. Ltd, the world's largest battery manufacturer.

Bloomberg

29 minutes ago

• Bloomberg

Murati's Thinking Machines Raises Cash at $10 Billion Valuation

Thinking Machines Lab, the artificial intelligence startup launched by former OpenAI executive Mira Murati, has raised close to $2 billion at a valuation of $10 billion before the investment, according to people familiar with the matter. Andreessen Horowitz led the funding round, with participation from Accel and Conviction Partners, among other investors, said the people, who asked not to be identified because the information is private. A spokesperson for Thinking Machines declined to comment. Representatives for the VC firms didn't comment. The Financial Times earlier reported some details of the funding.